Jump to content

3-Chloro-PCP: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
Citation bot (talk | contribs)
Add: doi-access. | Use this bot. Report bugs. | Suggested by Abductive | Category:Pharmacology stubs‎ | #UCB_Category 587/606
Line 14: Line 14:
}}
}}


'''3-Chloro-PCP''' ('''3'-Cl-PCP''') is a recreational [[designer drug]] from the [[arylcyclohexylamine]] family, with [[dissociative]] effects. It has comparable potency to [[phencyclidine]] but with a slightly different effects profile, being somewhat more potent as an [[NMDA antagonist]] but around the same potency as a [[dopamine reuptake inhibitor]].<ref name="pmid33633599">{{cite journal | vauthors = Catalani V, Arillotta D, Corkery JM, Guirguis A, Vento A, Schifano F | title = Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach | journal = Frontiers in Psychiatry | volume = 11 | issue = | pages = 632405 | date = 2020 | pmid = 33633599 | pmc = 7900492 | doi = 10.3389/fpsyt.2020.632405 }}</ref> It was first identified in Slovenia in December 2020,<ref>{{cite web | url = https://www.policija.si/apps/nfl_response_web/0_Analytical_Reports_final/3Cl-PCP-ID-2201-20_report.pdf | title = Analytical Report. 3Cl-PCP (C17H24ClN). 1‐[1‐(3‐chlorophenyl)cyclohexyl]piperidine. | work = National Forensic Laboratory | location = Slovenia }}</ref> and was made illegal in Hungary in April 2021.<ref>{{cite web | url = https://ec.europa.eu/growth/tools-databases/tris/index.cfm/en/search/?trisaction=search.detail&year=2021&num=225&dLang=EN | title = Amendment of Minister for Human Capacities Decree No 55/2014 on substances or groups of compounds classified as new psychoactive substances, 2021/225/HU | date = 30 December 2014 | work = Minister for Human Capacities }}</ref>
'''3-Chloro-PCP''' ('''3'-Cl-PCP''') is a recreational [[designer drug]] from the [[arylcyclohexylamine]] family, with [[dissociative]] effects. It has comparable potency to [[phencyclidine]] but with a slightly different effects profile, being somewhat more potent as an [[NMDA antagonist]] but around the same potency as a [[dopamine reuptake inhibitor]].<ref name="pmid33633599">{{cite journal | vauthors = Catalani V, Arillotta D, Corkery JM, Guirguis A, Vento A, Schifano F | title = Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach | journal = Frontiers in Psychiatry | volume = 11 | issue = | pages = 632405 | date = 2020 | pmid = 33633599 | pmc = 7900492 | doi = 10.3389/fpsyt.2020.632405 | doi-access = free }}</ref> It was first identified in Slovenia in December 2020,<ref>{{cite web | url = https://www.policija.si/apps/nfl_response_web/0_Analytical_Reports_final/3Cl-PCP-ID-2201-20_report.pdf | title = Analytical Report. 3Cl-PCP (C17H24ClN). 1‐[1‐(3‐chlorophenyl)cyclohexyl]piperidine. | work = National Forensic Laboratory | location = Slovenia }}</ref> and was made illegal in Hungary in April 2021.<ref>{{cite web | url = https://ec.europa.eu/growth/tools-databases/tris/index.cfm/en/search/?trisaction=search.detail&year=2021&num=225&dLang=EN | title = Amendment of Minister for Human Capacities Decree No 55/2014 on substances or groups of compounds classified as new psychoactive substances, 2021/225/HU | date = 30 December 2014 | work = Minister for Human Capacities }}</ref>


== See also ==
== See also ==

Revision as of 03:19, 30 July 2021

3-Chloro-PCP
Identifiers
  • 1-[1-(3-chlorophenyl)cyclohexyl]piperidine
PubChem CID
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC17H24ClN
Molar mass277.84 g·mol−1
3D model (JSmol)
  • C1CCC(CC1)(C2=CC(=CC=C2)Cl)N3CCCCC3
  • InChI=1S/C17H24ClN/c18-16-9-7-8-15(14-16)17(10-3-1-4-11-17)19-12-5-2-6-13-19/h7-9,14H,1-6,10-13H2
  • Key:HUHBTESMMFLCAN-UHFFFAOYSA-N

3-Chloro-PCP (3'-Cl-PCP) is a recreational designer drug from the arylcyclohexylamine family, with dissociative effects. It has comparable potency to phencyclidine but with a slightly different effects profile, being somewhat more potent as an NMDA antagonist but around the same potency as a dopamine reuptake inhibitor.[1] It was first identified in Slovenia in December 2020,[2] and was made illegal in Hungary in April 2021.[3]

See also

References

  1. ^ Catalani V, Arillotta D, Corkery JM, Guirguis A, Vento A, Schifano F (2020). "Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach". Frontiers in Psychiatry. 11: 632405. doi:10.3389/fpsyt.2020.632405. PMC 7900492. PMID 33633599.
  2. ^ "Analytical Report. 3Cl-PCP (C17H24ClN). 1‐[1‐(3‐chlorophenyl)cyclohexyl]piperidine" (PDF). National Forensic Laboratory. Slovenia.
  3. ^ "Amendment of Minister for Human Capacities Decree No 55/2014 on substances or groups of compounds classified as new psychoactive substances, 2021/225/HU". Minister for Human Capacities. 30 December 2014.